ConductScience.org, home

Paper40280970

Repurposing anti-viral subunit and mRNA vaccines T cell immunity for intratumoral immunotherapy against solid tumors.

Sethi SK and 6 others. NPJ Vaccines, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Repurposing anti-viral subunit and mRNA vaccines T cell immunity for intratumoral immunotherapy against solid tumors. Papers, record 40280970. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40280970

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Repurposing anti-viral subunit and mRNA vaccines T cell immunity for intratumoral immunotherapy against solid tumors.
PubMed
Journal
NPJ Vaccines
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.19, provisional
iCite
Revised in PubMed
2025-04-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sethi SKShiv K
2Bradley CEClaire E
3Bialkowski LLukas
4Pang YYYuk Ying
5Thompson CDCynthia D
6Schiller JTJohn T
7Çuburu NNicolas

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
NIHIntramural Research ProgramPubMedPubMed
NIHIntramural Research ProgramPubMedPubMed
NIHIntramural Research ProgramPubMedPubMed
NIHIntramural Research ProgramPubMedPubMed
NIHIntramural Research ProgramPubMedPubMed
NIHIntramural Research ProgramPubMedPubMed
NIHIntramural Research ProgramPubMedPubMed
ZIABC009052NIHNIH RePORTER
ZICBC010947NIHNIH RePORTER

Download CSV of grants

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135332327IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.Nat Immunol2022https://conductscience.org/library/papers/35332327PubMed
226659303Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells.Cancer Immunol Res2016https://conductscience.org/library/papers/26659303PubMed
332299851Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells.Science2020https://conductscience.org/library/papers/32299851PubMed
433767151Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling.Nat Commun2021https://conductscience.org/library/papers/33767151PubMed
535288714Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.Nat Immunol2022https://conductscience.org/library/papers/35288714PubMed
612854090Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.J Infect Dis2003https://conductscience.org/library/papers/12854090PubMed
731243491Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model.Cancer Immunol Immunother2019https://conductscience.org/library/papers/31243491PubMed
829567705Cancer immunotherapy using checkpoint blockade.Science2018https://conductscience.org/library/papers/29567705PubMed
923376950T-helper-1-cell cytokines drive cancer into senescence.Nature2013https://conductscience.org/library/papers/23376950PubMed
1032958686Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration.J Immunother Cancer2020https://conductscience.org/library/papers/32958686PubMed
1129769722Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.Nature2018https://conductscience.org/library/papers/29769722PubMed
1232999027Identification and Characterization of CD4+ T Cell Epitopes after Shingrix Vaccination.J Virol2020https://conductscience.org/library/papers/32999027PubMed
1316111635Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.Immunity2005https://conductscience.org/library/papers/16111635PubMed
1437576844State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop.Prev Med Rep2023https://conductscience.org/library/papers/37576844PubMed
1518591413Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity.J Exp Med2008https://conductscience.org/library/papers/18591413PubMed
1635853671Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy.J Immunother Cancer2022https://conductscience.org/library/papers/35853671PubMed
1729971321Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas.JAMA Dermatol2018https://conductscience.org/library/papers/29971321PubMed
1818797453Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.Mol Ther2008https://conductscience.org/library/papers/18797453PubMed
1929801750Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.Semin Immunol2018https://conductscience.org/library/papers/29801750PubMed
2031360870Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58.JNCI Cancer Spectr2018https://conductscience.org/library/papers/31360870PubMed

See all 59 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42372086Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hot.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42372086PubMed
42236116Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.J Immunother Cancer2026https://conductscience.org/library/papers/42236116PubMed
41058701The tumor immune microenvironment: implications for cancer immunotherapy, treatment strategies, and monitoring approaches.Front Immunol2025https://conductscience.org/library/papers/41058701PubMed
40872966Decrypting the Immune Symphony for RNA Vaccines.Vaccines (Basel)2025https://conductscience.org/library/papers/40872966PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CXCL94283PubTator's text mininghttps://conductscience.org/library/genes/4283NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40280970

GET https://conductscience.org/api/papers/v1/40280970/references?page=2